Search details
1.
Extremity Soft Tissue Sarcoma: A Multi-Institutional Validation of Prognostic Nomograms.
Ann Surg Oncol
; 29(5): 3291-3301, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35015183
2.
A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma.
J Surg Oncol
; 124(5): 829-837, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34254691
3.
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.
Oncologist
; 25(11): e1655-e1662, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32701199
4.
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial.
Lancet
; 388(10043): 488-97, 2016 Jul 30.
Article
in English
| MEDLINE | ID: mdl-27291997
5.
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 14(4): 371-82, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23477833
6.
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma.
Cancer Med
; 12(6): 7029-7038, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36464833
7.
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.
Cancer Med
; 12(2): 1532-1539, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35950293
8.
Cobimetinib Plus Vemurafenib in Patients With Solid Tumors With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
JCO Precis Oncol
; 7: e2300385, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-38096472
9.
Phase II Randomized Study of CMB305 and Atezolizumab Compared With Atezolizumab Alone in Soft-Tissue Sarcomas Expressing NY-ESO-1.
J Clin Oncol
; 40(12): 1291-1300, 2022 04 20.
Article
in English
| MEDLINE | ID: mdl-34260265
10.
Phase II Study of Pembrolizumab in Combination with Doxorubicin in Metastatic and Unresectable Soft-Tissue Sarcoma.
Clin Cancer Res
; 27(23): 6424-6431, 2021 12 01.
Article
in English
| MEDLINE | ID: mdl-34475102
11.
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma.
J Clin Oncol
; 37(16): 1424-1431, 2019 06 01.
Article
in English
| MEDLINE | ID: mdl-31013172
12.
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas.
J Clin Oncol
; 27(19): 3133-40, 2009 Jul 01.
Article
in English
| MEDLINE | ID: mdl-19451436
Results
1 -
12
de 12
1
Next >
>>